NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Astavakra.


I agree.

The Company also announced that the FDA has accepted an amendment of the clinical trial, which does not make any change in the treatment regimen, which leaves all data collected to date intact for use in the trial’s overall results, and which includes the following:

*Designation as a Phase III trial

*Expanded and enhanced statistical endpoint analyses….

*Addition of interim analyses for efficacy

[Emphasis Added]

-- May 17, 2012 NWBO Press Release